This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Sign In   |   Register
Share |

EAS support GCTC Survey

Good Clinical Trials Collaborative Global Survey - Clinical Trials and COVID-19

The Good Clinical Trials Collaborative invites you to take part in a global survey to understand the impact of COVID-19 on running clinical trials. Your feedback will contribute to the development of new guidelines that support a more efficient regulatory environment for clinical trials, allowing researchers to efficiently conduct the trials that are needed to improve patient care. The survey will be open for 6 weeks,  closing at 5pm (BST) on Monday 20 July 2020. 

Hear from Professor Martin Landray, the Good Clinical Trials Collaborative Lead, on why GCTC conducting this survey.


To the GCTC Clinical trials & Covid 19 survey>

To Good Clinical Trial Collebrative website >>

How will GCTC use your feedback? >>


ESC/EAS joint survey on new Dyslipidaemia Guidelines 

The joint ESC/EAS Task Force wanted to follow up on perception of the new dyslipidaemia guidelines and get an idea of current practice patterns regarding lipid management. And the joint survey was open from the beginning of November until December 15, 2019.

The 2019 ESC/EAS dyslipidaemia guidelines were released at ESC Congress 2019 in Paris. Substantial changes and updates in recommendations are included as compared with the previous (2016) guidelines.
New to the Guideline updates? Learn more >>

Survey about the knowledge and interest of EAS Members on the role of diet and lifestyle in the management of dyslipidaemia and prevention of CVD

Key points from the collected responses are now available

In order to get a better understanding of EAS members’ knowledge and interest in diet and lifestyle in the management of dyslipidaemia and the prevention of CVD we asked our members to complete a survey at the end of 2018. In the survey we asked also about the usefulness of currently available educational materials and the possible needs for new materials. Thank you to everyone who took part in the survey.

A summary of the Key Points from the collected responses is now available. The replies will inform the development of new educational materials & activities related to diet & lifestyle and their relation to CVD.


Joint ESC/EAS survey on current beliefs
and practices in lipid management

Thank you to everyone who took part in the survey. The survey is now closed, we're reviewing the responses and the feedback will inform the society's educational programmes to disseminate the guidelines. 

Think Again About Cholesterol

December 21, 2015. Our Think Again About Cholesterol survey results have been published as a supplement in Atherosclerosis! The survey was originally launched this September in support of World Heart Day and FH Awareness Day to raise awareness of the public’s understanding of cholesterol. The survey found there is a discrepancy between understanding the importance of high cholesterol and taking action against the risk for cardiovascular disease. In fact, although 89 percent of adults surveyed agreed it is important to know whether or not they have high low-density lipoprotein cholesterol (LDL-C), 92 percent did not know their cholesterol levels or never had their cholesterol levels tested. For more detailed survey results, check out Atherosclerosis Supplements 20 (2015) 1–5.

FH Studies Collaboration

March 2015. EAS-FH Studies Collaboration survey on the knowledge, attitudes and practices of physicians and healthcare professionals involved in the care of FH.
Before the FH Studies Collaboration Symposium we sent a short questionnaire to Congress delegates. The responses we received were pooled anonymously to generate summary data. We then re-issued the questionnaire in the weeks following the session, and have compared the results of both the pre- and post-session responses. These have been complied in a short presentation, and are now available to view. These results will be used in the ongoing work of the FH Studies Collaboration.

Membership Software Powered by YourMembership  ::  Legal